ATE126511T1 - 4,5-cycloalkano-3-benzazepin-7-ol-derivate und ihre verwendung. - Google Patents

4,5-cycloalkano-3-benzazepin-7-ol-derivate und ihre verwendung.

Info

Publication number
ATE126511T1
ATE126511T1 AT91904114T AT91904114T ATE126511T1 AT E126511 T1 ATE126511 T1 AT E126511T1 AT 91904114 T AT91904114 T AT 91904114T AT 91904114 T AT91904114 T AT 91904114T AT E126511 T1 ATE126511 T1 AT E126511T1
Authority
AT
Austria
Prior art keywords
alkoxy
alkyl
pct
phenyl
substituted phenyl
Prior art date
Application number
AT91904114T
Other languages
English (en)
Inventor
Theodros Asberom
Edward O'connor
Joel Gilbert Berger
John Welch Clader
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE126511T1 publication Critical patent/ATE126511T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91904114T 1990-02-02 1991-01-31 4,5-cycloalkano-3-benzazepin-7-ol-derivate und ihre verwendung. ATE126511T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47442890A 1990-02-02 1990-02-02

Publications (1)

Publication Number Publication Date
ATE126511T1 true ATE126511T1 (de) 1995-09-15

Family

ID=23883493

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91904114T ATE126511T1 (de) 1990-02-02 1991-01-31 4,5-cycloalkano-3-benzazepin-7-ol-derivate und ihre verwendung.

Country Status (12)

Country Link
US (1) US5362728A (de)
EP (1) EP0513174B1 (de)
JP (1) JPH0613474B2 (de)
KR (1) KR927003537A (de)
AT (1) ATE126511T1 (de)
AU (1) AU646432B2 (de)
CA (1) CA2075181C (de)
DE (1) DE69112201T2 (de)
ES (1) ES2075429T3 (de)
FI (1) FI923458L (de)
OA (1) OA09662A (de)
WO (1) WO1991011437A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1008622A3 (fr) * 1993-12-09 1996-06-04 Egyt Gyogyszervegyeszeti Gyar Derives de l'epi-epibatidine.
PT933993E (pt) 1996-06-14 2006-10-31 Biocryst Pharm Inc Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase
AU728332B2 (en) * 1997-06-23 2001-01-04 Kioka Gaishi Kogyo Kabushiki Kaisha Lock nut and attaching/removing tool for the same
DK1040094T3 (da) * 1997-12-17 2009-06-02 Biocryst Pharm Inc Substitueret cyklopentan og cyklopenten-forbindelser anvendelige som neuraminidase-inhibitorer
WO2000028328A1 (en) 1998-11-05 2000-05-18 Biocryst Pharmaceuticals, Inc. New cyclopentane and cyclopentene compounds and use for detecting influenza virus
US7411093B2 (en) * 2004-12-20 2008-08-12 Hoffman-La Roche Inc. Aminocycloalkanes as DPP-IV inhibitors
BRPI0615102A2 (pt) * 2005-08-30 2011-05-03 Abbott Lab composto, composições farmacêuticas como inibidores de dipeptidil peptidase-iv (dpp-iv), bem como uso
AU2008259841B2 (en) 2007-05-31 2015-02-05 Sunovion Pharmaceuticals Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
JP6272695B2 (ja) 2010-09-01 2018-01-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 体重管理のために有用な５−ｈｔ２ｃアゴニストの改変放出剤形
AU2011296015B2 (en) 2010-09-01 2015-11-12 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines
US3752892A (en) * 1970-03-11 1973-08-14 Ciba Geigy Corp Anorexigenic tetrahydrobenzazepine derivative method and composition thereof
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives
US4284555A (en) * 1979-04-27 1981-08-18 Schering Corporation 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4477378A (en) * 1980-02-05 1984-10-16 Schering Corp. Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4973586A (en) * 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
AU588080B2 (en) * 1986-01-16 1989-09-07 Schering Corporation Fused benzazepines
JPH0678317B2 (ja) * 1987-07-15 1994-10-05 シェリング・コーポレーション 縮合ベンズアゼピン

Also Published As

Publication number Publication date
ES2075429T3 (es) 1995-10-01
JPH05504769A (ja) 1993-07-22
EP0513174B1 (de) 1995-08-16
OA09662A (en) 1993-05-15
AU646432B2 (en) 1994-02-24
FI923458A0 (fi) 1992-07-31
FI923458A7 (fi) 1992-07-31
DE69112201T2 (de) 1996-02-15
AU7243291A (en) 1991-08-21
JPH0613474B2 (ja) 1994-02-23
FI923458L (fi) 1992-07-31
CA2075181A1 (en) 1991-08-03
EP0513174A1 (de) 1992-11-19
DE69112201D1 (de) 1995-09-21
US5362728A (en) 1994-11-08
CA2075181C (en) 1997-12-09
WO1991011437A1 (en) 1991-08-08
KR927003537A (ko) 1992-12-18

Similar Documents

Publication Publication Date Title
DE69223989D1 (en) Azyklische ethylendiaminderivate als 'substance p rezeptor' antagonisten
DE69512925D1 (de) Ortho-substituierte aromatische ether und ihre verwendung in schmerzstillenden pharmazeutischen zusammensetzungen
DE69316067D1 (de) Arzneimittel zur Verwendung bei der Behandlung von Parkinsonismus
ATE126511T1 (de) 4,5-cycloalkano-3-benzazepin-7-ol-derivate und ihre verwendung.
DK0572635T3 (da) Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne
ATE212996T1 (de) Anthracyclin-derivate
DE69104475D1 (de) Harnstoffderivate, ihre herstellung und deren enthaltende arzneimittel.
HRP950437A2 (en) N-substituted azabicycloheptane derivatives, their production and use
HUT76801A (en) 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and medicaments containing them
ES2094545T3 (es) Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc..
IL108288A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
DE69101097D1 (de) Verwendung von Triazin- und Pyrimidinderivaten zur Herstellung von Arzneimitteln zur Überwindung der Arzneimittelresistenz gegenüber Antikrebs- und Antimalariamittel.
ES8206537A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a) pirimidina
ATE170850T1 (de) Aminoalkylsubstituierte 5-mercaptothiazole, ihre herstellung und verwendung
EP0355169A4 (en) Antianxiety drug
NO305519B1 (no) Benzo[f]kinoksalindionderivater og legemidler inneholdende disse
PH31212A (en) 4-Amino-2-(hetero)aryl-butanamides useful as 5-HT1a-antagonists.
DE59104473D1 (de) Arzneimittel welche substituierte 2-Cyclohexen-1yl-amin-Derivate enthalten und ihre Verwendung zur Bekämpfung von Krankheiten.
AU5814386A (en) Substituted pyridine-1-oxides
FR2695643B1 (fr) Dérivés d'uréido-acétamide, leur préparation et les médicaments les contenant.
IT1261958B (it) 2-(sostituite immino)-tiazolidine e procedimento per la loro preparazione e loro impiego quali antianginose e/o analgesiche
NO923042L (no) 4,5-cykloalkano-3-benzazepin-7-ol-derivater og deres anvendelse
JO1648B1 (en) Nitrogen compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties